Economic benefit analysis of primary prevention with pravastatin. Modelling economic benefits after such long term treatment is inappropriate.
about
Economic benefit analysis of primary prevention with pravastatin. Modelling economic benefits after such long term treatment is inappropriate.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Economic benefit analysis of p ...... rm treatment is inappropriate.
@en
Economic benefit analysis of p ...... rm treatment is inappropriate.
@nl
type
label
Economic benefit analysis of p ...... rm treatment is inappropriate.
@en
Economic benefit analysis of p ...... rm treatment is inappropriate.
@nl
prefLabel
Economic benefit analysis of p ...... rm treatment is inappropriate.
@en
Economic benefit analysis of p ...... rm treatment is inappropriate.
@nl
P2860
P1433
P1476
Economic benefit analysis of p ...... rm treatment is inappropriate.
@en
P2093
P2860
P304
P356
10.1136/BMJ.316.7139.1241
P407
P577
1998-04-01T00:00:00Z